| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.03 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.03 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.03 |